BioSpace News Archive

Drug Development

Travere Therapeutics Announces Positive Topline Results from the Ongoing Phase 1/2 COMPOSE Study of Pegtibatinase in Classical Homocystinuria

Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced positive topline results from the ongoing Phase 1/2 COMPOSE Study of pegtibatinase, a novel investigational enzyme replacement therapy being evaluated for the treatment of classical homocystinuria (HCU).

December 15, 2021
·
10 min read
Business

MEDX Xelerator Commences $1 Million, Interventional Oncology Technology Challenge Chaired by Professor Stephen B. Solomon

MEDX Xelerator is scouting worldwide for disruptive products, ideas and unmet needs in interventional oncology and has commenced its first annual million dollar challenge in this pursuit.

December 15, 2021
·
2 min read
FDA

Nuvation Bio Receives FDA Fast Track Designation for NUV-422 for the Treatment of High-Grade Gliomas, Including Glioblastoma Multiforme

Nuvation Bio Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to NUV-422, a cyclin-dependent kinase (CDK) 2/4/6 inhibitor, for the treatment of patients with high-grade gliomas, including glioblastoma multiforme.

December 15, 2021
·
5 min read
Valence Discovery Announces $8.5 Million in Seed Funding to Scale AI-Based Generative Chemistry Engine and Collaborations with Leading Discovery Organizations

Valence’s AI-based generative chemistry engine designs novel chemical matter optimized for complex property profiles against high-value disease targets even in the absence of experimental data.

December 15, 2021
·
5 min read
Drug Development

Laurent Pharmaceuticals Extends COVID-19 Phase 2 Study with Oral Antiviral LAU-7b that has Showed 100% Reduction in the Risk of Progression onto Mechanical Ventilation and Death

FDA allows Phase 2 study extension focusing on moderate-to-severe COVID-19 patients and grants Type B meeting to discuss eligibility to Emergency Use Authorization (EUA) and Phase 3 clinical development.

December 15, 2021
·
5 min read
Business

KKR Completes Acquisition of Bettcher Industries and Names Dan Daniel Chairman

Bettcher Industries (“Bettcher” or the “Company”), a leading manufacturer and supplier of food processing equipment and associated aftermarket parts and consumables, and KKR, a leading global investment firm, today announced the completion of KKR’s acquisition of Bettcher from MPE Partners.

December 15, 2021
·
3 min read
Business

Santhera’s Shareholders Approve all Board Proposals at Today’s Extraordinary General Meeting

Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders have approved all proposals by the Board of Directors at the Extraordinary General Meeting (EGM) held today at the Company’s domicile in Pratteln, Switzerland.

December 15, 2021
·
3 min read
Drug Development

Polyphor and EnBiotix Announce Dosing of First Patient in a First-in-Human Clinical Trial of Inhaled Murepavadin

Polyphor AG and EnBiotix Inc. announced that the first subjects have been dosed in the first-in-human Phase I trial of a novel-class antibiotic murepavadin, delivered via the oral inhalation route.

December 15, 2021
·
3 min read
Deals

Aragen Acquires Intox Pvt. Ltd.

Aragen Life Sciences, a global research, development, and manufacturing solutions provider, announced that it has signed a definitive agreement to acquire Pune-based Intox Pvt. Ltd.

December 15, 2021
·
3 min read
Biotech Bay

SanBio Joins the Newly Formed National TBI Registry Coalition (NTRC) as a Founding Member Organization

The SanBio Group today announced it is one of the founding member organizations of the National TBI Registry Coalition (NTRC) in the United States.

December 15, 2021
·
4 min read